Viking Therapeutics Inc logo

Viking Therapeutics Inc

NEW
NAS:VKTX (USA)  
$ 29.73 +0.18 (+0.61%) 07:08 PM EST
At Loss
P/B:
3.77
Volume:
5.27M
Avg Vol (2M):
5.01M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
5.27M
At Loss
Avg Vol (2M):
5.01M

Business Description

Description
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Name Current Vs Industry Vs History
Cash-To-Debt 806.62
Equity-to-Asset 0.97
Debt-to-EBITDA -0.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 33.09
Quick Ratio 33.09
Cash Ratio 32.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6
Shareholder Yield % -17.99

Financials (Next Earnings Date:2025-04-24 Est.)

VKTX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VKTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Viking Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1
Beta 0.83
3-Year Sharpe Ratio 0.88
3-Year Sortino Ratio 3.57
Volatility % 51.31
14-Day RSI 42.01
14-Day ATR ($) 2.489069
20-Day SMA ($) 29.3515
12-1 Month Momentum % -59.01
52-Week Range ($) 24.4075 - 89.0997
Shares Outstanding (Mil) 112.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Viking Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Viking Therapeutics Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Viking Therapeutics Inc Frequently Asked Questions

What is Viking Therapeutics Inc(VKTX)'s stock price today?
The current price of VKTX is $29.73. The 52 week high of VKTX is $89.10 and 52 week low is $24.41.
When is next earnings date of Viking Therapeutics Inc(VKTX)?
The next earnings date of Viking Therapeutics Inc(VKTX) is 2025-04-24 Est..
Does Viking Therapeutics Inc(VKTX) pay dividends? If so, how much?
Viking Therapeutics Inc(VKTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1